Results 11 to 20 of about 93,628 (138)

LSD

open access: yesSouth African Medical Journal, 2018
Click on the link to view.
C. Vidal, W. R. Külpmann
  +5 more sources

Efficacy and safety of enzyme-replacement-therapy with agalsidase alfa in 36 treatment-naïve Fabry disease patients

open access: yesBMC Pharmacology and Toxicology, 2017
Background Fabry disease (FD) is an X-linked lysosomal storage disorder resulting from the α-galactosidase A gene mutations. Enzyme-replacement-therapy (ERT) products for FD currently used include agalsidase alfa and agalsidase beta.
Kazuya Tsuboi, Hiroshi Yamamoto
doaj   +1 more source

Lumpy skin disease: A newly emerging disease in Southeast Asia [PDF]

open access: yesVeterinary World, 2022
Lumpy skin disease (LSD) is caused by LSD virus (LSDV). This virus has been classified in the genus Capripoxvirus, family Poxviridae which generally affects large ruminants, especially cattle and domestic water buffalo.
Kanokwan Ratyotha   +2 more
doaj   +1 more source

Comparison of some morphological parameters during the adolescence stage

open access: yesJournal of Education, Health and Sport, 2019
The fastest changes in a child's growth and development occur during the puberty phase. The purpose of this research is based on this fact. The goal was to determine changes in the dynamics of growth and development of the morphological characteristics ...
Abdulla Elezi   +2 more
doaj   +1 more source

Update of Lumpy Skin Disease: Emergence in Asian Part of Eurasia

open access: yesActa Veterinaria, 2022
Lumpy skin disease (LSD) is an infectious disease mostly of cattle. The typical clinical picture is usually characterized by the appearance of multiple nodules on the skin and internal organs. They can cover the entire body of the animal in the course of
Saltykov Yuri V.   +2 more
doaj   +1 more source

Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin

open access: yesFrontiers in Pharmacology, 2021
The psychedelic lysergic acid diethylamide (LSD) has experienced a revival in research, including clinical trials that evaluate LSD-assisted psychotherapy.
Friederike Holze   +9 more
doaj   +1 more source

GM1 Gangliosidosis: Mechanisms and Management

open access: yesThe Application of Clinical Genetics, 2021
Allisandra K Rha,1 Anne S Maguire,1,2 Douglas R Martin1,2 1Scott-Ritchey Research Center, Auburn University, Auburn, AL, 36849, USA; 2Department of Anatomy, Physiology, and Pharmacology, Auburn University College of Veterinary Medicine, Auburn, AL, 36849,
Rha AK, Maguire AS, Martin DR
doaj  

Determination of Lysergic Acid Diethylamide and 2-Oxo-3-Hydroxy-LSD in Blood: Validation and Comparison of Two Liquid Chromatography–Tandem Mass Spectrometry Methods

open access: yesSeparations, 2023
Lysergic acid diethylamide (LSD) is a powerful hallucinogen. Its detection is limited by its low dosage; moreover, LSD is rapidly metabolized into 2-oxo-3-hydroxy-LSD (O-H-LSD).
Alexandra Dimitrova   +5 more
doaj   +1 more source

EASTERN MYSTICISM AND TIMOTHY LEARY: HUMAN BEYOND THE CONVENTIONAL REALITY

open access: yesAntropologìčnì Vimìri Fìlosofsʹkih Doslìdžen', 2017
Introduction. The complex multifaceted essence of human as a biological, psychological, social being has attracted the attention of researchers and has caused hot debates during centuries.
T. V. Danylova
doaj   +1 more source

Mass Spectrometry Evaluation of Biomarkers in the Vitreous Fluid in Gaucher Disease Type 3 with Disease Progression Despite Long-Term Treatment

open access: yesDiagnostics, 2020
Intraocular lesions have been infrequently reported in patients with Gaucher disease type 3 (GD3). We previously reported siblings with GD3 who responded well to the combination of enzyme replacement therapy (ERT) and substrate reduction therapy (SRT ...
Aizeddin Mhanni   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy